Search for Clinical Trial Results

Sponsored By

Hemolytic-Uremic Syndrome - 2 Studies Found

Status Study
Completed Study Name: Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
Condition: Shiga-like Toxin-producing Escherichia Coli
Date: 2011-08-03
Interventions: Drug: Eculizumab (Soliris®) Eculizumab 300 mg, 600 mg, 900 mg or 1200 mg will be administered intra
Withdrawn Study Name: The Plasma Large-Volume Exchange RCT
Condition:
  • Purpura, Thrombotic Thrombocytopenic
  • Hemolytic Uremic Syndrome<
    Date: 2011-09-09
    Interventions: Procedure: Plasma Exchange Plasma exchange is a blood purification technique that removes plasma from th